StockData
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. (OVID) stock

OVIDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$2.26+0.04 (+1.80%)

Close on Nov 18, 2026Market cap $441.37MP/E –Yield –

Ovid Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Ovid Therapeutics's pe ratio was 1.6× on Apr 29, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 20221.6×−0.2
2021Dec 31, 20211.8×–

More Ovid Therapeutics figures

See a number that looks wrong?